Literature DB >> 6813266

Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions.

L G Wayne, K Y Lin.   

Abstract

Tuberculosis is characterized by periods in which the disease may be quiescent or even clinically inapparent, but in which tubercle bacilli persist and retain the potential to reactivate the disease. The present study was carried out in pursuit of an in vitro model which might contribute to the understanding of the physiology of nonreplicating persisters, with oxygen limitation used as the means of inducing this state. When actively growing aerated cultures of Mycobacterium tuberculosis were suddenly placed under anaerobic conditions the bacilli died rapidly, with a half-life of 10 h. When the bacilli were grown in liquid medium without agitation, they adapted to the microaerophilic conditions encountered in the sediment; the adapted bacilli in the sediment did not replicate there but were tolerant of anaerobiosis, exhibiting a half-life of 116 h. Among the early events associated with the adaptation were the synthesis of an antigen designated URB, the function of which is not known, and a fourfold increase in isocitrate lyase activity. The bacilli later exhibited a 10-fold increase in synthesis of a glycine dehydrogenase that catalyzes the reductive amination of glyoxylate, concomitantly oxidizing NADH to NAD. Specific activities of other enzymes studied were either not affected or moderately diminished in the sedimented bacilli. It is proposed that the glyoxylate synthesis in this model serves mainly to provide a substrate for the regeneration of NAD that may be required for the orderly completion of the final cycle of bacillary replication before oxygen limitation stops growth completely. This orderly shutdown is essential to continued survival of M. tuberculosis in a quiescent form.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813266      PMCID: PMC347645          DOI: 10.1128/iai.37.3.1042-1049.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Enzyme systems in the mycobacteria. XIII. Glycine dehydrogenase and the glyoxylic acid cycle.

Authors:  D S GOLDMAN; M J WAGNER
Journal:  Biochim Biophys Acta       Date:  1962-12-04

2.  Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice.

Authors:  J L SEVER; G P YOUMANS
Journal:  Am Rev Tuberc       Date:  1957-10

3.  Inhibition of spleen diphosphopyridine nucleotidase by nicotinamide, an exchange reaction.

Authors:  L J ZATMAN; N O KAPLAN; S P COLOWICK
Journal:  J Biol Chem       Date:  1953-01       Impact factor: 5.157

4.  Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture.

Authors:  L G Wayne; G A Diaz
Journal:  J Bacteriol       Date:  1967-04       Impact factor: 3.490

5.  The mechanism of action of 5'-adenylic acid-activated threonine dehydrase.

Authors:  A T Phillips; W A Wood
Journal:  J Biol Chem       Date:  1965-12       Impact factor: 5.157

6.  Synchronized replication of Mycobacterium tuberculosis.

Authors:  L G Wayne
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

7.  Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions.

Authors:  L G Wayne
Journal:  Am Rev Respir Dis       Date:  1976-10

8.  Glyoxylate cycle in Mucor racemosus.

Authors:  B T O'Connell; J L Paznokas
Journal:  J Bacteriol       Date:  1980-07       Impact factor: 3.490

9.  Properties of threonine deaminase from a bacterium able to use threonine as sole source of carbon.

Authors:  T G Lessie; H R Whiteley
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

10.  The effect of organic acids on mammalian tubercle bacilli.

Authors:  R J DUBOS
Journal:  J Exp Med       Date:  1950-10-01       Impact factor: 14.307

View more
  100 in total

1.  Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model.

Authors:  C Boon; R Li; R Qi; T Dick
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

2.  The stringent response of Mycobacterium tuberculosis is required for long-term survival.

Authors:  T P Primm; S J Andersen; V Mizrahi; D Avarbock; H Rubin; C E Barry
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

3.  Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.

Authors:  L E Desjardin; L G Hayes; C D Sohaskey; L G Wayne; K D Eisenach
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

Review 4.  Tuberculosis: latency and reactivation.

Authors:  J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

Review 5.  Life and death in a macrophage: role of the glyoxylate cycle in virulence.

Authors:  Michael C Lorenz; Gerald R Fink
Journal:  Eukaryot Cell       Date:  2002-10

6.  Metronidazole therapy in mice infected with tuberculosis.

Authors:  J V Brooks; S K Furney; I M Orme
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

7.  Mycobacterium bovis BCG response regulator essential for hypoxic dormancy.

Authors:  Calvin Boon; Thomas Dick
Journal:  J Bacteriol       Date:  2002-12       Impact factor: 3.490

8.  Analysis of expression profile of mammalian cell entry (mce) operons of Mycobacterium tuberculosis.

Authors:  Ashwani Kumar; Mridula Bose; Vani Brahmachari
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

9.  Transcription of the stationary-phase-associated hspX gene of Mycobacterium tuberculosis is inversely related to synthesis of the 16-kilodalton protein.

Authors:  Y Hu; A R Coates
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

10.  In vitro model of mycobacterial growth arrest using nitric oxide with limited air.

Authors:  Syed Hussain; Muhammad Malik; Lanbo Shi; Maria Laura Gennaro; Karl Drlica
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.